Variant report
Variant | nsv573000 |
---|---|
Chromosome Location | chr16:76140126-76188325 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:164)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:10)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr16:76157853-76158224 | H1-hESC | embryonic stem cell: | n/a | chr16:76158029-76158040 |
2 | CEBPB | chr16:76157843-76158213 | Hela-S3 | cervix: | n/a | chr16:76158029-76158040 |
3 | CEBPB | chr16:76172099-76172368 | MCF-7 | breast: | n/a | n/a |
4 | CEBPB | chr16:76157892-76158146 | HepG2 | liver: | n/a | chr16:76158029-76158040 |
5 | CEBPB | chr16:76157854-76158207 | IMR90 | lung: | n/a | chr16:76158029-76158040 |
6 | CEBPB | chr16:76157859-76158197 | A549 | lung: | n/a | chr16:76158029-76158040 |
7 | CEBPB | chr16:76148545-76148883 | HepG2 | liver: | n/a | chr16:76148705-76148716 |
8 | CEBPB | chr16:76157851-76158221 | HepG2 | liver: | n/a | chr16:76158029-76158040 |
9 | CEBPB | chr16:76159866-76160102 | MCF-7 | breast: | n/a | chr16:76159936-76159949 |
10 | CEBPB | chr16:76148114-76148326 | HepG2 | liver: | n/a | chr16:76148205-76148216 |
11 | CEBPB | chr16:76148587-76148863 | IMR90 | lung: | n/a | chr16:76148705-76148716 |
12 | CEBPB | chr16:76157831-76158205 | MCF-7 | breast: | n/a | chr16:76158029-76158040 |
13 | CEBPB | chr16:76148575-76148856 | A549 | lung: | n/a | chr16:76148705-76148716 |
14 | CEBPB | chr16:76157877-76158203 | MCF-7 | breast: | n/a | chr16:76158029-76158040 |
15 | CEBPB | chr16:76157884-76158214 | K562 | blood: | n/a | chr16:76158029-76158040 |
16 | CTCF | chr16:76142316-76142440 | HepG2 | liver: | n/a | n/a |
17 | CTCF | chr16:76142280-76142430 | GM12874 | blood: | n/a | n/a |
18 | CTCF | chr16:76142241-76142431 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | CTCF | chr16:76155160-76155310 | Caco-2 | colon: | n/a | n/a |
20 | CTCF | chr16:76142280-76142430 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr16:76151543-76151606 | GM13976 | blood: | n/a | n/a |
22 | CTCF | chr16:76142302-76142407 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | CTCF | chr16:76142260-76142410 | Caco-2 | colon: | n/a | n/a |
24 | CTCF | chr16:76142280-76142430 | HEK293 | kidney: | n/a | n/a |
25 | CTCF | chr16:76142220-76142370 | GM12865 | blood: | n/a | n/a |
26 | CTCF | chr16:76142217-76142439 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | CTCF | chr16:76174386-76174441 | GM20000 | blood: | n/a | n/a |
28 | CTCF | chr16:76140725-76140799 | MCF-7 | breast: | n/a | n/a |
29 | CTCF | chr16:76142273-76142419 | HepG2 | liver: | n/a | n/a |
30 | CTCF | chr16:76140721-76140724 | MCF-7 | breast: | n/a | n/a |
31 | CTCF | chr16:76152458-76152502 | MCF-7 | breast: | n/a | n/a |
32 | CTCF | chr16:76142240-76142390 | HepG2 | liver: | n/a | n/a |
33 | CTCF | chr16:76140580-76140730 | GM12870 | blood: | n/a | n/a |
34 | E2F4 | chr16:76159770-76160191 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | E2F4 | chr16:76147254-76147427 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | E2F4 | chr16:76179258-76179432 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | E2F4 | chr16:76153720-76153920 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | EP300 | chr16:76150107-76150266 | K562 | blood: | n/a | n/a |
39 | FOS | chr16:76157904-76158161 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | FOS | chr16:76166363-76166615 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | FOS | chr16:76177179-76177465 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | FOS | chr16:76148848-76148859 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | FOS | chr16:76159736-76160149 | MCF10A-Er-Src | breast: | n/a | chr16:76159955-76159966 chr16:76159959-76159967 |
44 | FOS | chr16:76177159-76177471 | MCF10A-Er-Src | breast: | n/a | chr16:76177458-76177470 |
45 | FOS | chr16:76157869-76158119 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | FOS | chr16:76157904-76158181 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | FOS | chr16:76159750-76160389 | MCF10A-Er-Src | breast: | n/a | chr16:76159955-76159966 chr16:76159959-76159967 chr16:76160363-76160373 |
48 | FOS | chr16:76157924-76158187 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | FOS | chr16:76166398-76166537 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | FOS | chr16:76159756-76160398 | MCF10A-Er-Src | breast: | n/a | chr16:76159955-76159966 chr16:76159959-76159967 chr16:76160363-76160373 |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:76165281..76167806-chr16:76168616..76171411,2 | K562 | blood: | |
2 | chr16:76167106..76169562-chr16:76172402..76175397,2 | MCF-7 | breast: | |
3 | chr16:76170732..76173663-chr16:76174703..76177407,2 | MCF-7 | breast: | |
4 | chr16:76152673..76155052-chr16:76163507..76166139,2 | K562 | blood: | |
5 | chr16:76170732..76173663-chr16:76174703..76177407,2 | MCF-7 | breast: | |
6 | chr16:76150031..76151626-chr16:76156509..76159199,2 | MCF-7 | breast: | |
7 | chr16:76165281..76167806-chr16:76168616..76171411,2 | K562 | blood: | |
8 | chr16:76150031..76151626-chr16:76156509..76159199,2 | MCF-7 | breast: | |
9 | chr16:76167106..76169562-chr16:76172402..76175397,2 | MCF-7 | breast: | |
10 | chr16:76152673..76155052-chr16:76163507..76166139,2 | K562 | blood: |
(count:10 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AC025287.1-2 | chr16:76181458-76181704 | ENSG00000260223.1 |
2 | lnc-AC025287.1-2 | chr16:76170020-76170263 | ENSG00000260223.1 |
3 | lnc-AC025287.1-2 | chr16:76141181-76141401 | ENSG00000260223.1 |
4 | lnc-AC025287.1-2 | chr16:76169537-76169877 | NONHSAT143772 |
5 | lnc-AC025287.1-2 | chr16:76181458-76181677 | ENSG00000260223.1 |
6 | lnc-AC025287.1-2 | chr16:76181453-76181621 | NONHSAT143772 |
7 | lnc-AC025287.1-2 | chr16:76174260-76174301 | ENSG00000260223.1 |
8 | lnc-AC025287.1-2 | chr16:76169538-76169877 | XLOC_012013 |
9 | lnc-AC025287.1-2 | chr16:76142134-76142240 | ENSG00000260223.1 |
10 | lnc-AC025287.1-2 | chr16:76181454-76181621 | XLOC_012013 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000260223 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2432608 | chr16:76140126-76140127 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs538385102 | chr16:76140134-76140135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554521507 | chr16:76140142-76140143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116204855 | chr16:76140149-76140150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540307212 | chr16:76140172-76140173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183810692 | chr16:76140204-76140205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74863593 | chr16:76140218-76140219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551456544 | chr16:76140256-76140257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572945498 | chr16:76140363-76140364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560421196 | chr16:76140382-76140383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571222894 | chr16:76140392-76140393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150080973 | chr16:76140435-76140436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527505476 | chr16:76140454-76140455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547218838 | chr16:76140456-76140457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35151973 | chr16:76140488-76140489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2432416 | chr16:76140497-76140498 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs373651275 | chr16:76140503-76140504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550721386 | chr16:76140540-76140541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560848679 | chr16:76140541-76140542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113987244 | chr16:76140571-76140572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529728075 | chr16:76140572-76140573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2432607 | chr16:76140577-76140578 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs567063359 | chr16:76140584-76140585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556038345 | chr16:76140592-76140593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552496548 | chr16:76140610-76140611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114129742 | chr16:76140653-76140654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112859872 | chr16:76140661-76140662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188925122 | chr16:76140662-76140663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114780843 | chr16:76140673-76140674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574465983 | chr16:76140686-76140687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12917862 | chr16:76140692-76140693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138392090 | chr16:76140702-76140703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573043140 | chr16:76140733-76140734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377449505 | chr16:76140784-76140785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147193406 | chr16:76141185-76141186 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs2278056 | chr16:76141193-76141194 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs115311872 | chr16:76141204-76141205 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs140785484 | chr16:76141240-76141241 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs531751262 | chr16:76141282-76141283 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs548363720 | chr16:76141328-76141329 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs2278055 | chr16:76141342-76141343 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs527758523 | chr16:76141344-76141345 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs369233594 | chr16:76141371-76141372 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs547904669 | chr16:76141382-76141383 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs539203820 | chr16:76142134-76142135 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs531344700 | chr16:76142137-76142138 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs146854920 | chr16:76142138-76142139 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs544653750 | chr16:76142139-76142140 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs140870611 | chr16:76142140-76142141 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs189043262 | chr16:76142144-76142145 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:76138000-76140600 | Weak transcription | Gastric | stomach |
2 | chr16:76140600-76140800 | Enhancers | Gastric | stomach |
3 | chr16:76142200-76143000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr16:76149000-76149200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr16:76149000-76149600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr16:76149600-76155400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr16:76155400-76155600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr16:76157200-76158200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr16:76157400-76158200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr16:76158000-76158200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr16:76158200-76181400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr16:76159800-76160200 | Enhancers | HMEC | breast |
13 | chr16:76171400-76172000 | Enhancers | Placenta | Placenta |
14 | chr16:76174000-76176200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr16:76174200-76174600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr16:76174200-76175400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr16:76174400-76175800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr16:76175000-76175800 | Enhancers | Brain Hippocampus Middle | brain |
19 | chr16:76175200-76175600 | Enhancers | Brain Inferior Temporal Lobe | brain |
20 | chr16:76175200-76175800 | Enhancers | Brain Substantia Nigra | brain |
21 | chr16:76176600-76176800 | Enhancers | Brain Angular Gyrus | brain |
22 | chr16:76179400-76179600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |